Is Structure Therapeutics Inc. (GPCR) a Buy, Sell, or Hold?
Structure Therapeutics Inc.
NASDAQ:GPCR
$49.62 USD
-$0.97 (-1.92%)
- Volume
- 684.28K
- Average Volume
- 825.29K
- Market Capitalization
- $2.86B
- P/E Ratio
- -18.80
- Dividend Yield
- 0.00%
- Price Target
- $102.00
- Year High
- $94.90
- Year Low
- $15.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $26.16
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
26
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
33
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 320.02K
GPCR Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
GPCR Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-07-14 | M-Exempt | 0.34 | 2026-07-15 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-07-14 | C-Conversion | 0 | 2026-07-15 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-07-14 | M-Exempt | 0.34 | 2026-07-15 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-07-14 | C-Conversion | 0 | 2026-07-15 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-07-14 | S-Sale | 0 | 2026-07-15 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-07-14 | S-Sale | 0 | 2026-07-15 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-06-25 | M-Exempt | 0.34 | 2026-06-29 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-06-25 | C-Conversion | 0 | 2026-06-29 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-06-25 | M-Exempt | 0.34 | 2026-06-29 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-06-25 | C-Conversion | 0 | 2026-06-29 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-06-25 | S-Sale | 0 | 2026-06-29 |
| Russell Angus C. | director | 2026-06-17 | A-Award | 15 | 2026-06-18 |
| LOVE TED W | director | 2026-06-17 | A-Award | 15 | 2026-06-18 |
| Waldstreicher Joanne | director | 2026-06-17 | A-Award | 15 | 2026-06-18 |
| DOBMEIER ERIC | director | 2026-06-17 | A-Award | 15 | 2026-06-18 |
| TETLOW SHARON | director | 2026-06-17 | A-Award | 15 | 2026-06-18 |
| WELCH DANIEL G | director | 2026-06-17 | A-Award | 15 | 2026-06-18 |
| Lang Matthew | officer: COO & GC | 2026-04-15 | A-Award | 18.08 | 2026-04-23 |
| Lang Matthew | officer: COO & GC | 2026-04-15 | A-Award | 0 | 2026-04-23 |
| Lang Matthew | 2026-04-15 | 0 | 2026-04-23 | ||
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-04-14 | S-Sale | 0 | 2026-04-16 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-04-14 | S-Sale | 0 | 2026-04-16 |
| Hall Ashley | officer: Chief Development Officer | 2026-03-19 | A-Award | 0 | 2026-03-23 |
| Hall Ashley | officer: Chief Development Officer | 2026-03-19 | A-Award | 16.82 | 2026-03-23 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | 2026-03-19 | A-Award | 0 | 2026-03-23 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | 2026-03-19 | A-Award | 16.82 | 2026-03-23 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | 2026-03-19 | A-Award | 0 | 2026-03-23 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | 2026-03-19 | A-Award | 16.82 | 2026-03-23 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-03-19 | A-Award | 0 | 2026-03-23 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-03-19 | A-Award | 16.82 | 2026-03-23 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2026-03-19 | A-Award | 0 | 2026-03-23 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2026-03-19 | A-Award | 16.82 | 2026-03-23 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | 2026-03-19 | A-Award | 0 | 2026-03-23 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | 2026-03-19 | A-Award | 16.82 | 2026-03-23 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | 2026-03-03 | F-InKind | 20.99 | 2026-03-05 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | 2026-03-03 | F-InKind | 20.99 | 2026-03-05 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2026-03-03 | F-InKind | 20.99 | 2026-03-05 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2026-03-03 | F-InKind | 20.99 | 2026-03-05 |
| Hall Ashley | officer: Chief Development Officer | 2026-03-03 | F-InKind | 20.99 | 2026-03-05 |
| Hall Ashley | officer: Chief Development Officer | 2025-11-20 | A-Award | 0 | 2026-03-05 |
| Hall Ashley | officer: Chief Development Officer | 2025-05-20 | A-Award | 0 | 2026-03-05 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | 2026-03-03 | F-InKind | 20.99 | 2026-03-05 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | 2025-11-20 | A-Award | 0 | 2026-03-05 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-01-15 | S-Sale | 0 | 2026-01-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-01-15 | S-Sale | 0 | 2026-01-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-01-15 | S-Sale | 0 | 2026-01-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-01-15 | S-Sale | 0 | 2026-01-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-01-15 | S-Sale | 0 | 2026-01-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-01-15 | S-Sale | 0 | 2026-01-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-01-15 | S-Sale | 0 | 2026-01-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2026-01-15 | S-Sale | 0 | 2026-01-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-12-08 | S-Sale | 0 | 2025-12-10 |
| Hall Ashley | officer: Chief Development Officer | 2025-09-18 | F-InKind | 7.7433 | 2025-09-22 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | 2025-09-18 | F-InKind | 7.7433 | 2025-09-22 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | 2025-07-01 | F-InKind | 6.8366 | 2025-08-20 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2025-07-01 | F-InKind | 6.8366 | 2025-08-20 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 2025-07-30 | S-Sale | 0 | 2025-08-01 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | 2025-07-01 | A-Award | 0 | 2025-07-03 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | 2025-07-01 | F-InKind | 6.8366 | 2025-07-03 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | 2025-03-01 | F-InKind | 7.9166 | 2025-07-03 |
| Coll Crespo Blas | officer: CHIEF MEDICAL OFFICER | 2025-05-21 | A-Award | 0 | 2025-07-03 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | 2025-07-01 | A-Award | 0 | 2025-07-03 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | 2025-03-01 | F-InKind | 7.9166 | 2025-07-03 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2025-07-01 | A-Award | 0 | 2025-07-03 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2025-03-01 | F-InKind | 7.9166 | 2025-07-03 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2025-07-01 | A-Award | 0 | 2025-07-03 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2025-07-01 | F-InKind | 6.8366 | 2025-07-03 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2025-03-01 | F-InKind | 7.9166 | 2025-07-03 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2025-05-21 | A-Award | 0 | 2025-07-03 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | 2025-07-01 | A-Award | 0 | 2025-07-03 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | 2025-07-01 | F-InKind | 6.8366 | 2025-07-03 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | 2025-03-01 | F-InKind | 7.9166 | 2025-07-03 |
| Stevens Raymond C | director, officer: CHIEF EXECUTIVE OFFICER | 2025-05-21 | A-Award | 0 | 2025-07-03 |
| Russell Angus C. | director | 2025-06-23 | A-Award | 7.37 | 2025-06-25 |
| LOVE TED W | director | 2025-06-23 | A-Award | 7.37 | 2025-06-25 |
| Waldstreicher Joanne | director | 2025-06-23 | A-Award | 7.37 | 2025-06-25 |
| DOBMEIER ERIC | director | 2025-06-23 | A-Award | 7.37 | 2025-06-25 |
| TETLOW SHARON | director | 2025-06-23 | A-Award | 7.37 | 2025-06-25 |
| WELCH DANIEL G | director | 2025-06-23 | A-Award | 7.37 | 2025-06-25 |
| Coll Crespo Blas | officer: Chief Medical Officer | 2025-03-15 | A-Award | 7.02 | 2025-03-18 |
| Coll Crespo Blas | officer: Chief Medical Officer | 2025-03-15 | A-Award | 0 | 2025-03-18 |
| Coll Crespo Blas | officer: Chief Medical Officer | 2024-11-20 | A-Award | 0 | 2025-03-18 |
| Hall Ashley | officer: Chief Development Officer | 2025-03-15 | A-Award | 7.02 | 2025-03-18 |
| Hall Ashley | officer: Chief Development Officer | 2025-03-15 | A-Award | 0 | 2025-03-18 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | 2025-03-15 | A-Award | 7.02 | 2025-03-18 |
| Ma Yingli | officer: CHIEF TECHNOLOGY OFFICER | 2025-03-15 | A-Award | 0 | 2025-03-18 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2025-03-15 | A-Award | 7.02 | 2025-03-18 |
| Lin Xichen | officer: CHIEF SCIENTIFIC OFFICER | 2025-03-15 | A-Award | 0 | 2025-03-18 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2025-03-15 | A-Award | 0 | 2025-03-18 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2025-03-15 | A-Award | 7.02 | 2025-03-18 |
| Yoon Jun | officer: CHIEF FINANCIAL OFFICER | 2024-11-20 | A-Award | 0 | 2025-03-18 |